Literature DB >> 15099349

Mutations in the hMLH1 gene in Slovenian patients with gastric carcinoma.

P Hudler1, K Vouk, K Voulk, M Liovic, S Repse, R Juvan, R Komel.   

Abstract

Alterations of multiple oncogenes and tumor suppressor genes, together with genetic instability, are responsible for carcinogenesis in gastric cancer. The microsatellite mutator phenotype is the cause of many somatic frameshift and point mutations in non-coding repetitive sequences and in coding regions associated with cell proliferation and apoptosis. Genetic mutations in hMLH1 and transcriptional silencing of its promoter by hypermethylation lead to the inactivation of the mismatch repair system. In our study, we screened for mutations the hMLH1 gene in patients expressing the microsatellite instability genotype by using single-strand conformational polymorphism analysis and direct sequencing. Seven changes were identified; of these, three (A92P, E433Q, and K618A) were germline mutations and the other four (IVS5 453 + 79 A > G, I219V, 1039 - 7 del (T)(n), and IVS15 1668 - 19 A > G) germline polymorphisms. A92P and E433Q are novel, previously unidentified mutations. In addition, we found a rather complex distribution of mutations and polymorphisms in individual patients and in two cases also a methylated hMLH1 promoter.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15099349     DOI: 10.1111/j.0009-9163.2004.0234.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

1.  The germline MLH1 K618A variant and susceptibility to Lynch syndrome-associated tumors.

Authors:  Fabiola Medeiros; Noralane M Lindor; Fergus J Couch; W Edward Highsmith
Journal:  J Mol Diagn       Date:  2012-03-13       Impact factor: 5.568

2.  Non-truncating hMLH1 variants identified in Slovenian gastric cancer patients are not associated with Lynch Syndrome: a functional analysis report.

Authors:  Matjaz Vogelsang; Radovan Komel
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

3.  Significance of genetic abnormalities of p53 protein in Slovenian patients with gastric carcinoma.

Authors:  Robert Juvan; Petra Hudler; Barbara Gazvoda; Stanislav Repse; Matej Bracko; Radovan Komel
Journal:  Croat Med J       Date:  2007-04       Impact factor: 1.351

4.  Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma.

Authors:  John DeSisto; John T Lucas; Ke Xu; Andrew Donson; Tong Lin; Bridget Sanford; Gang Wu; Quynh T Tran; Dale Hedges; Chih-Yang Hsu; Gregory T Armstrong; Michael Arnold; Smita Bhatia; Patrick Flannery; Rakeb Lemma; Lakotah Hardie; Ulrich Schüller; Sujatha Venkataraman; Lindsey M Hoffman; Kathleen Dorris; Jean M Mulcahy Levy; Todd C Hankinson; Michael Handler; Arthur K Liu; Nicholas Foreman; Rajeev Vibhakar; Kenneth Jones; Sariah Allen; Jinghui Zhang; Suzanne J Baker; Thomas E Merchant; Brent A Orr; Adam L Green
Journal:  Nat Commun       Date:  2021-09-20       Impact factor: 17.694

5.  Difficulties in finding DNA mutations and associated phenotypic data in web resources using simple, uncomplicated search terms, and a suggested solution.

Authors:  Elizabeth A Webb; Timothy D Smith; Richard G H Cotton
Journal:  Hum Genomics       Date:  2011-03       Impact factor: 4.639

Review 6.  Genetic aspects of gastric cancer instability.

Authors:  Petra Hudler
Journal:  ScientificWorldJournal       Date:  2012-04-19

7.  MLH1 Ile219Val Polymorphism in Argentinean Families with Suspected Lynch Syndrome.

Authors:  Mev Dominguez-Valentin; Patrik Wernhoff; Andrea R Cajal; Pablo G Kalfayan; Tamara A Piñero; Maria L Gonzalez; Alejandra Ferro; Ines Sammartino; Natalia S Causada Calo; Carlos A Vaccaro
Journal:  Front Oncol       Date:  2016-08-24       Impact factor: 6.244

8.  Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast.

Authors:  Matjaz Vogelsang; Aleksandra Comino; Neja Zupanec; Petra Hudler; Radovan Komel
Journal:  BMC Cancer       Date:  2009-10-28       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.